C-Aryl glucosides substituted at the 4′-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes Article

Xu, Baihua, Feng, Yan, Cheng, Huawei et al. (2011). C-Aryl glucosides substituted at the 4′-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes . BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 21(15), 4465-4470. 10.1016/j.bmcl.2011.06.032

cited authors

  • Xu, Baihua; Feng, Yan; Cheng, Huawei; Song, Yanli; Lv, Binhua; Wu, Yuelin; Wang, Congna; Li, Shengbin; Xu, Min; Du, Jiyan; Peng, Kun; Dong, Jiajia; Zhang, Wenbin; Zhang, Ting; Zhu, Liangcheng; Ding, Haifeng; Sheng, Zelin; Welihinda, Ajith; Roberge, Jacques Y; Seed, Brian; Chen, Yuanwei

authors

publication date

  • August 1, 2011

published in

keywords

  • ANTIDIABETIC AGENTS
  • C-Aryl glucosides
  • CYCLOPROPANATION
  • Chemistry
  • Chemistry, Medicinal
  • Chemistry, Organic
  • DAPAGLIFLOZIN
  • Diabetes
  • Glucosuria
  • Life Sciences & Biomedicine
  • MECHANISM
  • MELLITUS
  • Pharmacology & Pharmacy
  • Physical Sciences
  • REABSORPTION
  • SGLT2
  • Science & Technology
  • Sodium-dependent glucose co-transporter
  • T-1095
  • Type 2 diabetes mellitus

Digital Object Identifier (DOI)

publisher

  • PERGAMON-ELSEVIER SCIENCE LTD

start page

  • 4465

end page

  • 4470

volume

  • 21

issue

  • 15